Javascript must be enabled to continue!
Mirror therapy for patients with severe arm paresis after stroke – a randomized controlled trial
View through CrossRef
Objective:
To evaluate the effects of individual or group mirror therapy on sensorimotor function, activities of daily living, quality of life and visuospatial neglect in patients with a severe arm paresis after stroke.
Design:
Randomized controlled trial.
Setting:
Inpatient rehabilitation centre.
Subject:
Sixty patients with a severe paresis of the arm within three months after stroke.
Interventions:
Three groups: (1) individual mirror therapy, (2) group mirror therapy and (3) control intervention with restricted view on the affected arm.
Main measures:
Motor function on impairment (Fugl-Meyer Test) and activity level (Action Research Arm Test), independence in activities of daily living (Barthel Index), quality of life (Stroke Impact Scale) and visuospatial neglect (Star Cancellation Test).
Results:
After five weeks, no significant group differences for motor function were found (
P
> 0.05). Pre–post differences for the Action Research Arm Test and Fugl-Meyer Test: individual mirror therapy: 3.4 (7.1) and 3.2 (3.8), group mirror therapy: 1.1 (3.1) and 5.1 (10.0) and control therapy: 2.8 (6.7) and 5.2 (8.7). However, a significant effect on visuospatial neglect for patients in the individual mirror therapy compared to control group could be shown (
P
< 0.01). Furthermore, it was possible to integrate a mirror therapy group intervention for severely affected patients after stroke.
Conclusion:
This study showed no effect on sensorimotor function of the arm, activities of daily living and quality of life of mirror therapy compared to a control intervention after stroke. However, a positive effect on visuospatial neglect was indicated.
SAGE Publications
Title: Mirror therapy for patients with severe arm paresis after stroke – a randomized controlled trial
Description:
Objective:
To evaluate the effects of individual or group mirror therapy on sensorimotor function, activities of daily living, quality of life and visuospatial neglect in patients with a severe arm paresis after stroke.
Design:
Randomized controlled trial.
Setting:
Inpatient rehabilitation centre.
Subject:
Sixty patients with a severe paresis of the arm within three months after stroke.
Interventions:
Three groups: (1) individual mirror therapy, (2) group mirror therapy and (3) control intervention with restricted view on the affected arm.
Main measures:
Motor function on impairment (Fugl-Meyer Test) and activity level (Action Research Arm Test), independence in activities of daily living (Barthel Index), quality of life (Stroke Impact Scale) and visuospatial neglect (Star Cancellation Test).
Results:
After five weeks, no significant group differences for motor function were found (
P
> 0.
05).
Pre–post differences for the Action Research Arm Test and Fugl-Meyer Test: individual mirror therapy: 3.
4 (7.
1) and 3.
2 (3.
8), group mirror therapy: 1.
1 (3.
1) and 5.
1 (10.
0) and control therapy: 2.
8 (6.
7) and 5.
2 (8.
7).
However, a significant effect on visuospatial neglect for patients in the individual mirror therapy compared to control group could be shown (
P
< 0.
01).
Furthermore, it was possible to integrate a mirror therapy group intervention for severely affected patients after stroke.
Conclusion:
This study showed no effect on sensorimotor function of the arm, activities of daily living and quality of life of mirror therapy compared to a control intervention after stroke.
However, a positive effect on visuospatial neglect was indicated.
Related Results
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
Hypertension, Age, Sex, and Stroke Incidence In Stroke Installation Room RSUD dr. M. Yunus BengkuluABSTRAKStroke adalah gejala-gejala defisit fungsi susunan saraf yang diakibatka...
Unveiling the Burden of Cardiovascular Disorders in Pediatric Stroke—Insights from Pakistan
Unveiling the Burden of Cardiovascular Disorders in Pediatric Stroke—Insights from Pakistan
Pediatric stroke, though relatively uncommon, poses significant clinical challenges due to its high rates of morbidity and mortality [1]. Its incidence varies with age, remaining l...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Non-Hodgkin Lymphoma: A Phase I/II Study.
Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Non-Hodgkin Lymphoma: A Phase I/II Study.
Abstract
Allogeneic hematopoietic cell transplantation (HCT) using reduced intensity conditioning (RIC) regimens offers a potential curative therapy to patients with...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...

